We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $73.4B Turnover 30.34%
1-Year Est. Return 32.8%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+15.23%
1 Year Est. Return
+32.8%
3 Year Est. Return
+177.41%
5 Year Est. Return
+184.82%
10 Year Est. Return
+833.33%
AUM
$110B
AUM Growth
+$18.7B
Cap. Flow
+$7.09B
Cap. Flow %
6.45%
Top 10 Hldgs %
8.73%
Holding
3,883
New
532
Increased
1,751
Reduced
1,103
Closed
466
Avg Time Held
2.3 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$618M
2
VALE icon
Vale
VALE
+$332M
3
CELG
Celgene
CELG
+$309M
4
CME icon
CME Group
CME
+$306M
5
AMZN icon
Amazon
AMZN
+$290M

Sector Composition

Rank Sector Weight
1 Healthcare 16.72%
2 Technology 14.76%
3 Financials 10.86%
4 Consumer Discretionary 10.67%
5 Real Estate 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VRSN icon
1
VeriSign
VRSN
$27.9B
$1.33B 1.21%
7,330,876
+299,876
+4% +$51.4M
2013 Q2
23 quarters
NVO icon
2
Novo Nordisk
NVO
$184B
$1.12B 1.02%
42,689,832
+1,200,690
+3% +$29.5M
2013 Q2
23 quarters
PANW icon
3
Palo Alto Networks
PANW
$260B
$1.09B 0.99%
26,904,900
+1,078,200
+4% +$40M
2015 Q2
15 quarters
CMG icon
4
Chipotle Mexican Grill
CMG
$45.1B
$1.04B 0.94%
73,019,950
+10,997,000
+18% +$128M
2016 Q4
9 quarters
VRTX icon
5
Vertex Pharmaceuticals
VRTX
$136B
$934M 0.85%
5,078,717
+744,417
+17% +$137M
2017 Q1
8 quarters
PEP icon
6
PepsiCo
PEP
$201B
$881M 0.8%
7,188,514
-91,736
-1% -$10.5M
2013 Q2
23 quarters
HUM icon
7
Humana
HUM
$55.1B
$828M 0.75%
3,111,000
-396,800
-11% -$114M
2015 Q2
15 quarters
VMW
8
DELISTED
VMware
VMW
$827M 0.75%
4,582,800
-450,668
-9% -$73.4M
2014 Q3
18 quarters
SBUX icon
9
Starbucks
SBUX
$123B
$823M 0.75%
11,073,986
+8,988,102
+431% +$618M
2018 Q4
1 quarter
DUK icon
10
Duke Energy
DUK
$102B
$734M 0.67%
8,156,229
-53,550
-0.7% -$4.72M
2014 Q1
20 quarters
DPZ icon
11
Domino's
DPZ
$11.4B
$716M 0.65%
2,773,500
-312,000
-10% -$81.1M
2013 Q2
23 quarters
AMGN icon
12
Amgen
AMGN
$252B
$667M 0.61%
3,508,583
-70,017
-2% -$13.4M
2013 Q2
23 quarters
META icon
13
Meta Platforms (Facebook)
META
$1.6T
$643M 0.58%
3,858,696
-2,150,666
-36% -$342M
2018 Q2
3 quarters
ALGN icon
14
Align Technology
ALGN
$11.7B
$643M 0.58%
2,260,000
-259,481
-10% -$61.9M
2013 Q2
23 quarters
GSK icon
15
GSK
GSK
$102B
$596M 0.54%
11,418,080
+2,104,160
+23% +$105M
2013 Q2
23 quarters
BMY icon
16
Bristol-Myers Squibb
BMY
$129B
$589M 0.54%
12,351,175
+5,404,300
+78% +$269M
2016 Q2
11 quarters
ABMD
17
DELISTED
Abiomed Inc
ABMD
$589M 0.54%
2,060,923
+191,200
+10% +$63.5M
2015 Q1
16 quarters
PBR icon
18
Petrobras
PBR
$112B
$553M 0.5%
34,718,800
+8,429,500
+32% +$134M
2016 Q2
11 quarters
BP icon
19
BP
BP
$116B
$532M 0.48%
12,371,407
+647,707
+6% +$26.5M
2017 Q2
7 quarters
GILD icon
20
Gilead Sciences
GILD
$209B
$528M 0.48%
8,120,248
+2,730,700
+51% +$181M
2014 Q4
17 quarters
MOH icon
21
Molina Healthcare
MOH
$11.9B
$525M 0.48%
3,695,205
-294,350
-7% -$39.8M
2013 Q2
23 quarters
PGR icon
22
Progressive
PGR
$137B
$521M 0.47%
7,226,596
-604,800
-8% -$41.4M
2015 Q4
13 quarters
RL icon
23
Ralph Lauren
RL
$22.9B
$510M 0.46%
3,934,994
+348,794
+10% +$41.5M
2015 Q1
16 quarters
CCI icon
24
Crown Castle
CCI
$38.1B
$500M 0.45%
3,903,300
-2,079,403
-35% -$244M
2015 Q1
16 quarters
MOMO icon
25
Hello Group
MOMO
$621M
$494M 0.45%
12,927,803
+1,482,100
+13% +$47.4M
2016 Q3
10 quarters

Similar funds

Jim Simons's Q1 2019 Portfolio in Review

As of Q1 2019, Jim Simons held 3,883 positions worth $110B, up 20% from $91.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Jim Simons deployed $7.09B of net new capital in Q1 2019, opening 532 new positions and adding to 1,751 existing holdings. Its largest new stake was Amazon: 3,483,100 shares worth $310M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $342M trimmed.

  • Jim Simons's largest Q1 2019 buy was Amazon: 3,483,100 shares worth $310M.
  • Jim Simons added most to Starbucks in Q1 2019, an estimated $618M increase.
  • Jim Simons's biggest Q1 2019 reduction was Meta Platforms (Facebook), cutting an estimated $342M.
  • Jim Simons fully exited Apple in Q1 2019, selling an estimated $435M.
  • Jim Simons's ten largest holdings make up 8.7% of its $110B portfolio in Q1 2019.
  • Jim Simons opened 532 new positions and closed 466 in Q1 2019.
  • Jim Simons's portfolio value rose 20% quarter-over-quarter to $110B.

Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.